Title

Antibiotics for bronchiolitis in children under two years of age

Date of this Version

1-1-2014

Document Type

Journal Article

Publication Details

Citation only

Farley, R., Spurling, G. K. P., Eriksson, L., & Del Mar, C. B. (2014). Antibiotics for bronchiolitis in children under two years of age. The Cochrane Database of Systematic Reviews, 10(10).

Access the journal

© Copyright, The Cochrane Collaboration, 2014

ISSN

1469-493X

Abstract

Bronchiolitis is a serious, potentially life-threatening respiratory illness commonly affecting babies. It is often caused by respiratory syncytial virus (RSV). Antibiotics are not recommended for bronchiolitis unless there is concern about complications such as secondary bacterial pneumonia or respiratory failure. Nevertheless, they are often used. Objectives To evaluate the effectiveness of antibiotics for bronchiolitis in children under two years of age compared to placebo or other interventions. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2014, Issue 6), which includes the Cochrane Acute Respiratory Infection Group’s Specialised Register, and the Database of Abstracts of Reviews of Effects, MEDLINE (1966 to June 2014), EMBASE (1990 to June 2014) and Current Contents (2001 to June 2014). Selection criteria Randomised controlled trials (RCTs) comparing antibiotics to placebo in children under two years diagnosed with bronchiolitis, using clinical criteria (including respiratory distress preceded by coryzal symptoms with or without fever). Primary clinical outcomes included time to resolution of signs or symptoms (pulmonary markers included respiratory distress, wheeze, crepitations, oxygen saturation and fever). Secondary outcomes included hospital admissions, length of hospital stay, readmissions, complications or adverse events and radiological findings. Data collection and analysis Two review authors independently analysed the search results. Main results We included seven studies with a total of 824 participants. The results of these seven included studies were often heterogeneous, which generally precluded meta-analysis, except for deaths, length of supplemental oxygen use and length of hospital admission.

 

This document has been peer reviewed.